Perspectives in cutaneous photodynamic sensitization

Journal of Photochemistry and Photobiology B: Biology

Volumn 36, Issue 2, 1996, Pages 209-211

  Ortel, B ^a,d   Calzavara Pinton, P G ^b   Szeimies, R M ^c   Hasan, T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d Department of Dermatology ^*  (United States)

Author keywords

Aminolevulinic acid; Photodynamic therapy; Photosensitizer; Porphyrin

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSAN; PHOTOSENSITIZING AGENT; PORPHYRIN; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIGHT ABSORPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

HEMATOPORPHYRIN DERIVATIVE; HUMANS; PHOTOCHEMOTHERAPY; SKIN DISEASES;

EID: 0030293942     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07374-5     Document Type: Conference Paper

References (14)

1. [1] J.C. Kennedy, R.H. Pottier and D.C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol. B: Biol., 6 (1990) 143-148.
2. [2] G. Jori and E. Reddi, The role of lipoproteins in the delivery of tumour-targeting photosensitizers, Int. J. Biochem., 25 (1993) 1369-1375.
3. [3] T. Hasan, Photosensitizer delivery mediated by macromolecular carrier systems, in B.W. Henderson and T.J. Dougherty (eds.), Photodynamic Therapy, Marcel Dekker, New York, 1992, pp. 187-200.
4. [4] R.-M. Szeimies, P.G. Calzavara-Pinton, S. Karrer, B. Ortel and M. Landthaler, Topical photodynamic therapy in dermatology, J. Photochem. Photobiol. B: Biol., 36 (1996).
5. [5] P.G. Calzavara-Pinton, R.-M. Szeimies, B. Ortel and C. Zane, Photodynamic therapy with systemic administration of photosensitizers in dermatology, J. Photochem. Photobiol. B: Biol., 36 (1996).
6. [6] T.J. Dougherty, M.T. Cooper and T.S. Mang, Cutaneous phototoxic occurrences in patients receiving photofrin, Lasers Surg. Med., 10 (1990) 485-488.
7. [7] W.S. Chan, J.F. Marshall, R. Svensen, J. Bedwell and I.R. Hart, Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminium phthalocyanine, Cancer Res., 50 (1990) 4533-4538.
8. [8] C. Richert, J.M. Wessels, M. Muller, M. Kisterl, T. Benninghaus and A.E. Goetz, Photodynamic antitumor agents: beta-methoxyl groups give access to functionalized porphycenes and enhanced cellular uptake and activity, J. Med. Chem., 37 (1994) 2797-2807.
9. [9] H. Lui, Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update, Semin. Oncol., 21 (1994) 11-14.
10. [10] C.A. Megerian, S.I. Zaidi, R.C. Sprecher, S. Setrakian, D.W. Stepnick, N.L. Oleinick and H. Mukhtar, Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice, Laryngoscope, 103 (1993) 967-975.
11. [11] J.S. Nelson, W.G. Roberts and M.W. Berns, In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy, Cancer Res., 47 (1987) 4681-4685.
12. [12] L. Cincotta, J.W. Foley, T. MacEachern, E. Lampros and A.H. Cincotta, Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas, Cancer Res., 54 (1994) 1249-1258.
13. [13] B. Ortel, A. Tanew and H. Hönigsmann, Lethal photosensitization by endogenous porphyrins of PAM cells - modification by desferrioxamine, J Photochem. Photobiol. B: Biol., 17 (1993) 273-278.
14. [14] N. Schoenfeld, R. Mamet, Y. Nordenberg, M. Shafran, T. Babushkin and Z. Malik, Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation, Int. J. Cancer, 56 (1994) 106-112.